Venkataraman Sriram
Venture Investor/General Partner at RVL Pharmaceuticals plc; Director, 10% owner at OPTN; Director, 10% owner at LNTH
- Sold, on record
- $131M
- Dollars the filings state
- Form 4 sales
- 4
- Latest Nov 25, 2019
- Form 144 notices
- 2
- Proposed sales
- Companies
- 3
- Filed as an executive or holder
Companies
- RVL Pharmaceuticals plcVenture Investor/General Partner
- OPTNOptiNose, Inc.Director, 10% owner
- LNTHLantheus Holdings, Inc.Director, 10% owner
Sales by reason
Form 4 sales per year, every sale on record.
Sales by company
Shares sold, every Form 4 sale on record.
Timeline
- 1 Form 4 sale LNTHUnusualNov 21, 2016 2016
Sold 2.5M shares at $9.00 ($22.5M)
Venkataraman Sriram, Director, 10% owner
Sold 36.9% of holdings ($61M position)4.3M shares leftFirst sale on recordFiling
- 2 Form 4 sale LNTHUnusualMar 17, 2017 +116 days
Sold 3M shares at $12.20 ($36.6M)
Venkataraman Sriram, Director, 10% owner
Sold 46.6% of holdings ($78.6M position)3.4M shares leftFiling
- 3 Form 4 sale OPTNUnusualJun 11, 2018 +451 days
Sold 2.9M shares at $20.92 ($60.1M)
Venkataraman Sriram, Director, 10% owner
Sold 76.6% of holdings ($78.5M position)878,757 shares leftFirst sale on recordFiling
- 4 Form 4 sale OPTNUnusualNov 25, 2019 +532 days
Sold 1.3M shares at $9.17 ($11.5M)
Venkataraman Sriram, Director, 10% owner
Sold 60.7% of holdings ($18.9M position)807,995 shares leftFiling
- 5 Form 144 notice RVL Pharmaceuticals plcNoticeAug 24, 2023 +1368 days
Filed to sell 140,767 shares ($20k)
Venkataraman Sriram, Venture Investor/General Partner
No 10b5-1 planFirst sale on recordFiling
- 6 Form 144 notice RVL Pharmaceuticals plcNoticeAug 30, 2023 +6 days
Filed to sell 160,078 shares ($16k)
Venkataraman Sriram, Venture Investor/General Partner
No 10b5-1 planFirst sale on recordFiling
Every transaction
Loading transactions…
Sales and notices (6)
| Source | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Aug 30, 2023 | Aug 30, 2023 | RVL Pharmaceuticals plc | Venture Investor/General Partner | Form 144 notice | 160,078 | $16k | Notice | SEC | |
| Aug 24, 2023 | Aug 24, 2023 | RVL Pharmaceuticals plc | Venture Investor/General Partner | Form 144 notice | 140,767 | $20k | Notice | SEC | |
| Nov 25, 2019 | Nov 26, 2019 | OPTN | Director, 10% owner | Form 4 sale | 1.3M | $11.5M | 60.7% | Unusual | SEC |
| Jun 11, 2018 | Jun 13, 2018 | OPTN | Director, 10% owner | Form 4 sale | 2.9M | $60.1M | 76.6% | Unusual | SEC |
| Mar 17, 2017 | Mar 21, 2017 | LNTH | Director, 10% owner | Form 4 sale | 3M | $36.6M | 46.6% | Unusual | SEC |
| Nov 21, 2016 | Nov 23, 2016 | LNTH | Director, 10% owner | Form 4 sale | 2.5M | $22.5M | 36.9% | Unusual | SEC |